AChE inhibitors as rivastigmine [17], donepezil, or galantamine [18] are currently the most effective agents to treat cognitive symptoms of AD and have other possible therapeutic applications in the treatment of other neurodegenerative disorders. This evidence concerns the gene ACHE and Alzheimer disease.